OncoSil Medical design, develop and control the manufacture of radioactive particles in the area of oncology. The Board of Directors and Top Management of OncoSil Medical are committed to the highest standards of Quality, as described in the Quality Manual and associated documentation.
All members of OncoSil Medical are responsible for ensuring that this Policy Statement is understood and carried out. OncoSil Medical is committed to comply with the requirements of ISO 13485:2016 and to maintain the effectiveness of the Quality Management System. The Quality Management System is reviewed regularly, in accordance with the Documents Management procedure and as required. OncoSil Medical is committed to achieving excellence in its business operations, including the design and manufacture of medical devices in accordance with all applicable regulatory requirements. It wishes to be among the very best in its sector, providing a leading treatment for patients with solid mass forming tumours. As the quality and safety of products and services provided by the business relies on its employees, OncoSil Medical is committed to ensure its manufacturing operations and critical subcontractors deliver high quality products to its customers. OncoSil Medical believes that, to achieve this goal, every member of the company must be personally committed to, and fully supported in, their pursuit of business objectives. In this common endeavour, each of us have particular skills and experience to contribute.